Epithelial discoidin domain-containing receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:01, 1 June 2025) (edit) (undo)
 
(8 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='4bkj' size='340' side='right' caption='Human DDR1 kinase domain complex with imatinib and ethylene glycol (PDB code [[4bkj]])' scene=''>
+
<StructureSection load='4bkj' size='400' side='right' caption='Human DDR1 kinase domain complex with imatinib and ethylene glycol (PDB code [[4bkj]])' scene='80/805011/Cv/1'>
== Function ==
== Function ==
-
'''Epithelial discoidin domain-containing receptor''' (DDR1 and DDR2) are extracellular matrix-sensing receptors [[Tyrosine kinase]] which are activated by collagen and are expressed in bronchial epithelium. They are responsible for maintaining the normal structure of skin and kidney epithelia<ref>PMID:20884741</ref>. DDR1 and DDR2 function as sensors for extracellular matrix and to regulate a wide range of cell functions from migration and proliferation to cytokine secretion and extracellular matrix homeostasis/remodeling<ref name = "DDR1">PMID:24361528</ref>.
+
'''Epithelial discoidin domain-containing receptor''' (DDR1 and DDR2) are extracellular matrix-sensing [[Receptor tyrosine kinases]] which are activated by collagen and are expressed in bronchial epithelium. They are responsible for maintaining the normal structure of skin and kidney epithelia<ref>PMID:20884741</ref>. DDR1 and DDR2 function as sensors for extracellular matrix and to regulate a wide range of cell functions from migration and proliferation to cytokine secretion and extracellular matrix homeostasis/remodeling<ref name = "DDR1">PMID:24361528</ref>.
 +
 
 +
See also [[Kinase-linked, enzyme-linked and related receptors]].
== Disease ==
== Disease ==
Line 17: Line 19:
== Structural highlights ==
== Structural highlights ==
-
DDR1 contains a discoidin domain. This domain is about 150 amino acid long and is found in many blood coagulation factors. The structure of the complex between DDR1 and imatinib shows 6 hydrogen bonds interactions between the anti-cancer drug and the kinase domain including two bonds with the kinase allosteric site Asp-Phe-Gly (DFG motif)<ref>PMID:24768818</ref>.
+
DDR1 contains a discoidin domain. This domain is about 150 amino acid long and is found in many blood coagulation factors. The structure of the <scene name='80/805011/Cv/3'>complex between DDR1 and imatinib</scene> shows hydrogen bonds interactions between the anti-cancer drug and the kinase domain including bonds with the <scene name='80/805011/Cv/4'>kinase allosteric site Asp-Phe-Gly (DFG motif)</scene><ref>PMID:24768818</ref>. Water molecules are shown as red spheres.
</StructureSection>
</StructureSection>
Line 26: Line 28:
{{#tree:id=OrganizedByTopic|openlevels=0|
{{#tree:id=OrganizedByTopic|openlevels=0|
-
*Epithelial discoidin domain-containing receptor 1; Domains – discoidin 26-186; ligand-binding 283-385; kinase 543-838
+
*Epithelial discoidin domain-containing receptor 1; Domains – discoidin 26-186; ligand-binding 283-385; kinase 543-913
-
**[[5bvk]] – hDDR1 kinase domain 564-913 – human<br />
+
**[[5bvk]], [[6y23]] – hDDR1 kinase domain – human<br />
-
**[[3zos]], [[4bkj]] – hDDR1 kinase domain + cancer drug<br />
+
**[[3zos]], [[4bkj]], [[6bsd]] – hDDR1 kinase domain + cancer drug<br />
**[[6few]] – hDDR1 kinase domain + alport syndrome drug<br />
**[[6few]] – hDDR1 kinase domain + alport syndrome drug<br />
-
**[[6fex]], [[6fil]], [[6fim]], [[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br />
+
**[[6fex]], [[6fil]],[[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br />
-
**[[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[6brj]], [[6gwr]] – hDDR1 kinase domain + inhibitor<br />
+
**[[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[5sau]], [[5saw]], [[5sax]], [[5say]], [[5saz]], [[5sb0]], [[5sb1]], [[5sb2]], [[6brj]], [[6gwr]], [[6hp9]], [[7bcm]], [[7be6]], [[7feh]] – hDDR1 kinase domain + inhibitor<br />
**[[4ag4]] – hDDR1 29-367 domain + antibody<br />
**[[4ag4]] – hDDR1 29-367 domain + antibody<br />
 +
**[[8pe9]] – hDDR1 188-370 domain + antibody<br />
*Epithelial discoidin domain-containing receptor 2
*Epithelial discoidin domain-containing receptor 2
Line 39: Line 42:
**[[2z4f]] – hDDR2 discoidin domain – NMR<br />
**[[2z4f]] – hDDR2 discoidin domain – NMR<br />
**[[2wuh]] – hDDR2 discoidin domain + collagen<br />
**[[2wuh]] – hDDR2 discoidin domain + collagen<br />
-
**[[6fer]] – hDDR2 kinase domain + inhibitor<br />
+
**[[6fer]], [[7aym]] – hDDR2 kinase domain + inhibitor<br />
}}
}}
== References ==
== References ==

Current revision

Human DDR1 kinase domain complex with imatinib and ethylene glycol (PDB code 4bkj)

Drag the structure with the mouse to rotate

3D structures of epithelial discoidin domain-containing receptor

Updated on 01-June-2025

References

  1. Roberts ME, Magowan L, Hall IP, Johnson SR. Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. Eur Respir J. 2011 Jun;37(6):1482-93. doi: 10.1183/09031936.00039710. Epub 2010, Sep 30. PMID:20884741 doi:http://dx.doi.org/10.1183/09031936.00039710
  2. 2.0 2.1 Borza CM, Pozzi A. Discoidin domain receptors in disease. Matrix Biol. 2014 Feb;34:185-92. doi: 10.1016/j.matbio.2013.12.002. Epub 2013 Dec, 19. PMID:24361528 doi:http://dx.doi.org/10.1016/j.matbio.2013.12.002
  3. Song J, Chen X, Bai J, Liu Q, Li H, Xie J, Jing H, Zheng J. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells. Tumour Biol. 2016 Aug;37(8):11509-21. doi: 10.1007/s13277-016-5021-2. Epub 2016, Mar 28. PMID:27020590 doi:http://dx.doi.org/10.1007/s13277-016-5021-2
  4. Toy KA, Valiathan RR, Nunez F, Kidwell KM, Gonzalez ME, Fridman R, Kleer CG. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat. 2015 Feb;150(1):9-18. doi: 10.1007/s10549-015-3285-7., Epub 2015 Feb 10. PMID:25667101 doi:http://dx.doi.org/10.1007/s10549-015-3285-7
  5. Canning P, Tan L, Chu K, Lee SW, Gray NS, Bullock AN. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors. J Mol Biol. 2014 Apr 22. pii: S0022-2836(14)00198-3. doi:, 10.1016/j.jmb.2014.04.014. PMID:24768818 doi:http://dx.doi.org/10.1016/j.jmb.2014.04.014

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky

Personal tools